Assessing Differences in Attitudes toward Occupational Safety and Health Measures for Infection Control between Office and Assembly Line Employees during the COVID-19 Pandemic in Germany: A Cross-Sectional Analysis of Baseline Data from a Repeated Employee Survey.

COVID-19 pandemic baseline data infection control measures occupational SARS-CoV-2 risk of infection occupational safety and health workforce working conditions workplace health

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
29 12 2022
Historique:
received: 17 11 2022
revised: 21 12 2022
accepted: 22 12 2022
entrez: 8 1 2023
pubmed: 9 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

In our study, we investigated possible differences across occupational groups regarding employees’ perceived work-related risk of infection with SARS-CoV-2, attitudes toward technical, organisational, and personal occupational safety and health (OSH) measures for infection control, and factors associated with this attitude. We analysed baseline data (10 August to 25 October 2020) from a repeated standardised online survey distributed at a worldwide leading global supplier of technology and services in Germany. 2144 employees (32.4% women; age (mean ± SD): 44 ± 11 years) who worked predominantly remotely (n = 358), at an on-site office (n = 1451), and assembly line/manufacturing (n = 335) were included. The work-related SARS-CoV-2 risk of infection differed between office employees working remotely and on-site (mean ± SD = 2.9 ± 1.5 vs. 3.2 ± 1.5; Mann-Whitney-U-Test: W = 283,346; p < 0.002; ε2 = 0.01) and between on-site office and assembly line/manufacturing employees (3.8 ± 1.7; W = 289,174; p < 0.001; ε2 = 0.02). Attitude scores toward technical OSH-measures differed between remote and on-site office (4.3 ± 0.5 vs. 4.1 ± 0.6; W = 216,787; p < 0.001; ε2 = 0.01), and between on-site office and assembly line/manufacturing employees (3.6 ± 0.9; W = 149,881; p < 0.001; ε2 = 0.07). Findings were similar for organisational and personal measures. Affective risk perception, COVID-19-specific resilience, and information about COVID-19-related risks were associated with the employees’ attitudes. To promote positive attitudes, it seems to be important to consider occupational-group-specific context factors when implementing OSH-measures for infection control.

Identifiants

pubmed: 36612934
pii: ijerph20010614
doi: 10.3390/ijerph20010614
pmc: PMC9819385
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int Arch Occup Environ Health. 2019 Apr;92(3):435-451
pubmed: 30756179
Int J Environ Res Public Health. 2020 Sep 10;17(18):
pubmed: 32927758
J Public Health (Oxf). 2020 Nov 23;42(4):672-678
pubmed: 32657323
Scand J Work Environ Health. 2022 Jan 1;48(1):61-70
pubmed: 34788471
Front Public Health. 2021 May 31;9:678926
pubmed: 34136459
Int J Health Policy Manag. 2022 Mar 01;11(3):344-353
pubmed: 32772010
Appl Psychol. 2021 Jan;70(1):85-119
pubmed: 33362328
Appl Psychol. 2021 Jan;70(1):3-15
pubmed: 33821077
J Med Internet Res. 2020 Jun 16;22(6):e19782
pubmed: 32501801
BMJ Open. 2020 Nov 18;10(11):e043908
pubmed: 33208339
Vaccines (Basel). 2022 Aug 30;10(9):
pubmed: 36146511
Front Psychol. 2021 Dec 24;12:805790
pubmed: 35035377
Front Psychol. 2021 Jan 13;11:577331
pubmed: 33519593
Int J Environ Res Public Health. 2021 Feb 16;18(4):
pubmed: 33669365
Am J Ind Med. 2021 Apr;64(4):227-237
pubmed: 33491195
PLoS One. 2020 Apr 28;15(4):e0232452
pubmed: 32343747
Occup Environ Med. 2022 Jun;79(6):403-411
pubmed: 35022260
Lancet Reg Health Eur. 2021 Sep;8:100185
pubmed: 34345876
Global Health. 2021 Mar 29;17(1):34
pubmed: 33781283
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Psychosoc Med. 2006 Oct 18;3:Doc05
pubmed: 19742072
Appl Psychol Health Well Being. 2021 Nov;13(4):986-995
pubmed: 34032388
Int J Psychol. 2021 Aug;56(4):532-550
pubmed: 33615477
Annu Rev Psychol. 2011;62:391-417
pubmed: 20809791
Soc Sci Med. 2021 Sep;285:114222
pubmed: 34418734
BMC Oral Health. 2021 Nov 19;21(1):584
pubmed: 34798843
Appl Psychol. 2021 Jan;70(1):188-215
pubmed: 33362330
Int Arch Occup Environ Health. 2022 Aug;95(6):1401-1413
pubmed: 35298684
Sci Rep. 2022 Feb 15;12(1):2502
pubmed: 35169174
Lancet Digit Health. 2021 Feb;3(2):e76-e77
pubmed: 33509387
Eur J Public Health. 2016 Jun;26(3):478-85
pubmed: 27060594
Gesundheitswesen. 2009 Oct;71(10):685-93
pubmed: 19806536
Transbound Emerg Dis. 2022 Jul;69(4):e871-e882
pubmed: 34730277
Z Psychol. 2015;223(4):257-266
pubmed: 27453806
BMC Health Serv Res. 2019 Jan 21;19(1):53
pubmed: 30665401
Euro Surveill. 2021 Oct;26(42):
pubmed: 34676821

Auteurs

Jana Soeder (J)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany.

Anna T Neunhöffer (AT)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany.

Anke Wagner (A)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany.

Christine Preiser (C)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany.

Benjamin Rebholz (B)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany.

Diego Montano (D)

Department of Population-Based Medicine, Institute of Health Sciences, University Hospital Tübingen, Hoppe-Seyler-Straße 9, 72076 Tübingen, Germany.

Norbert Schmitz (N)

Department of Population-Based Medicine, Institute of Health Sciences, University Hospital Tübingen, Hoppe-Seyler-Straße 9, 72076 Tübingen, Germany.

Johanna Kauderer (J)

Medical Services, Robert Bosch GmbH, P.O. Box 10 60 50, 70049 Stuttgart, Germany.

Falko Papenfuss (F)

Medical Services, Robert Bosch GmbH, P.O. Box 10 60 50, 70049 Stuttgart, Germany.

Antje Klink (A)

Medical Services, Robert Bosch GmbH, P.O. Box 10 60 50, 70049 Stuttgart, Germany.

Karina Alsyte (K)

Medical Services, Robert Bosch GmbH, P.O. Box 10 60 50, 70049 Stuttgart, Germany.

Monika A Rieger (MA)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany.

Esther Rind (E)

Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, University Tübingen, Wilhelmstraße 27, 72074 Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH